ELVN Key Financial Ratios - Enliven Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	64.07	—	-11.64%	-11.83%
2026-03-31	40.32	—	-21.25%	-21.79%
2025-12-31	28.66	—	-21.78%	-22.56%
2025-09-30	32.95	—	-19.80%	-20.42%
2025-06-30	32.58	—	-19.89%	-20.52%
2025-03-31	21.06	—	-31.34%	-32.89%
2024-12-31	19.99	—	-27.33%	-28.73%
2024-09-30	17.44	—	-27.90%	-29.55%
2024-06-30	14.39	—	-25.33%	-27.16%
2024-03-31	13.47	—	-23.22%	-25.05%
2023-12-31	10.28	—	-26.33%	-29.11%
2023-09-30	22.24	—	-22.54%	-23.60%
2023-06-30	30.96	—	-17.87%	-18.48%
2023-03-31	27.23	—	-14.43%	-15.00%
2022-12-31	8	—	-45.21%	49.02%
2022-09-30	32.51	—	-71.79%	62.31%
2022-06-30	19.46	—	-70.40%	77.54%
2022-03-31	10.87	—	-61.02%	98.39%
2021-12-31	12.86	—	-54.87%	119.81%
2021-09-30	14.75	—	-45.39%	-48.89%
2021-06-30	10.23	—	-65.35%	-72.90%
2021-03-31	14.6	—	-54.36%	-58.74%
2020-12-31	14.47	—	-45.53%	-48.98%
2020-09-30	18.78	—	-37.03%	-39.17%
2020-06-30	22.81	—	-28.11%	-29.44%
2020-03-31	22.19	—	-24.01%	-25.18%
2019-12-31	7.29	—	-70.46%	48.03%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	28.66	—	-21.78%	-22.56%
2024-12-31	19.99	—	-27.33%	-28.73%
2023-12-31	10.28	—	-26.33%	-29.11%
2022-12-31	8	—	-45.21%	49.02%
2021-12-31	12.86	—	-54.87%	119.81%
2020-12-31	14.47	—	-45.53%	-48.98%
2019-12-31	7.29	—	-70.46%	48.03%